Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Klass Russell Kevin. Director active across 1 company, notably Zomedica Corp.. In total, 11 reports have been published. Split: 11 buys · 0 sell. Total volume traded: €208k. Activity tracked since 10 June 2024. The latest transaction was filed on 13 November 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Klass Russell Kevin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
200,007 shares@ US$0.149720.0% of flowCommon Stock, without par valueSEC:0001654954-24-007663:0
Canonical exit: 8 Sept 2024 (T+90)
11 of 11 declarations
About Klass Russell Kevin
Klass Russell Kevin is a declarant associated with Zomedica Corp. as Sr Vice President of Sales. He has 4 filings in total, and across the 4 sampled recent filings between 2024-06-12 and 2025-03-18, all are acquisitions, with total buy volume of EUR 139416 and no sell volume.